Hua Xu

10PUBLICATIONS
16CO-AUTHORS
Wastewater treatment processesMolecular targetsPredictive and prognostic markersNephrology and urologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 10, 2026
G6PC Downregulation Promotes Renal Calcium Oxalate Stone Formation via Lactate-Induced SNAIL1 K206 Lactylation and Epithelial-Mesenchymal Transition.

|Apr 17, 2023
Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma.

Junhui Hu, Ping Tan, Moe Ishihara

|Oct 18, 2021
The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis.

Xiangyang Yao, Haoran Liu, Hua Xu

|Sep 13, 2021
XIST Inhibition Attenuates Calcium Oxalate Nephrocalcinosis-Induced Renal Inflammation and Oxidative Injury via the miR-223/NLRP3 Pathway.

Peng Lv, Haoran Liu, Tao Ye

|Jan 31, 2020
Risk Factors for Urosepsis after Minimally Invasive Percutaneous Nephrolithotomy in Patients with Preoperative Urinary Tract Infection.

Shen Wang, Peng Yuan, Ejun Peng

|Apr 25, 2019
Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma.

Junhui Hu, Wei Guan, Libin Yan

Pageof 2

Frequent Collaborators

2 joint publications

Junhui Hu

2 joint publications

Zhangqun Ye

1 joint publications

Guohua Zeng

1 joint publications

Wei Guan